Efficacy and Safety of Pimavanserin for Treating Dementia-Related Psychosis in Lewy Body Dementia Patients: Insights from the HARMONY Trial - Top-Institutions - MDSpire

Efficacy and Safety of Pimavanserin for Treating Dementia-Related Psychosis in Lewy Body Dementia Patients: Insights from the HARMONY Trial

  • By

  • Yasar Torres-Yaghi

  • Lambros Chrones

  • Victor Abler

  • Greg Brunson

  • November 24, 2025

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Movement Disorders
    • Neuropsychiatry
  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Neurodegenerative Disease Research
    • Psychiatry
  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Movement Disorders
    • Neuropsychiatry
  • #4

    Massachusetts General Hospital (MGH)
    Massachusetts General Hospital (MGH)

    Boston, MA

    Key Differentiators

    • Neurology
    • Neurodegenerative Disorders
    • Psychiatry
  • #5

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, PA

    Key Differentiators

    • Neurology
    • Neuropsychiatry
    • Movement Disorders

Original Source(s)

Related Content